Filice G A, Yeager A S, Remington J S
J Clin Microbiol. 1980 Sep;12(3):336-42. doi: 10.1128/jcm.12.3.336-342.1980.
Failure to demonstrate immunoglobulin M (IgM) antibodies by indirect immunofluorescence (IgM-IFA) in sera from some patients with acute acquired toxoplasmosis has recently been attributed to an inhibitory effect of high titers of IgG antibodies in these sera (Pyndiah et al. J. Clin. Microbiol. 9:170-174, 1979). To confirm these findings and define their importance for diagnosis, we used gel filtration to separate IgM from IgG antibodies in a series of sera that were negative in the IgM-IFA test. A total of 68 sera were from patients with acquired toxoplasmosis, 13 were from uninfected adults, 13 were from infants with congenital toxoplasmosis, and 7 were from uninfected neonates. Of the 68 sera from patients with acquired toxoplasmosis, IgM preparations (from the separated sera) were positive in the IgM-IFA test in 36 (53%). There was a significant (P = 0.00003) association between high titers of IgM-IFA antibodies in the IgM preparations (corrected for dilution of IgM antibodies by the gel filtration procedure) and recent acquisition of infection. IgM antibodies were also detected in 5 (38%) of the IgM preparations of 13 sera from congenitally infected infants but not in any of the IgM preparations of sera from uninfected neonates. IgG antibodies to Toxoplasma gondii were shown to interfere with demonstration of IgM antibodies in the IgM-IFA test. Treatment of sera with protein A resulted in greater dilution of IgM antibodies and less efficient separation of IgM from IgG antibodies than did separation of sera by gel filtration. Treatment of sera with protein A did not result in increased detection of IgM antibodies to T. gondii. Testing of IgM preparations (obtained by gel filtration) resulted in a significant increase in sensitivity of the IgM-IFA test for the diagnosis of recently acquired and congenital toxoplasmosis.
最近,在一些急性获得性弓形虫病患者的血清中,通过间接免疫荧光法(IgM-IFA)未能检测到免疫球蛋白M(IgM)抗体,这归因于这些血清中高滴度IgG抗体的抑制作用(Pyndiah等人,《临床微生物学杂志》9:170 - 174,1979年)。为了证实这些发现并确定其对诊断的重要性,我们使用凝胶过滤法从一系列在IgM-IFA试验中呈阴性的血清中分离IgM和IgG抗体。共有68份血清来自获得性弓形虫病患者,13份来自未感染的成年人,13份来自先天性弓形虫病婴儿,7份来自未感染的新生儿。在68份获得性弓形虫病患者的血清中,IgM制剂(从分离的血清中获得)在IgM-IFA试验中36份呈阳性(53%)。IgM制剂中高滴度的IgM-IFA抗体(经凝胶过滤程序对IgM抗体稀释校正后)与近期感染的获得之间存在显著关联(P = 0.00003)。在13份先天性感染婴儿的血清中,5份(38%)的IgM制剂也检测到了IgM抗体,但未感染新生儿血清的任何IgM制剂中均未检测到。结果表明,弓形虫IgG抗体在IgM-IFA试验中会干扰IgM抗体的检测。与通过凝胶过滤分离血清相比,用蛋白A处理血清导致IgM抗体稀释度更高,且IgM与IgG抗体的分离效率更低。用蛋白A处理血清并未导致对弓形虫IgM抗体检测的增加。对(通过凝胶过滤获得的)IgM制剂进行检测,使IgM-IFA试验对近期获得性和先天性弓形虫病诊断的敏感性显著提高。